Stockscreener 앱 받기
1.4608
1.01%
-0.0192
Pulmonx Corp 주식(LUNG)의 최신 뉴스
Price to earnings forward of Pulmonx Corp. – LSX:A2P1AF - TradingView
Price to sales forward of Pulmonx Corp. – DUS:4NI - TradingView
Pulmonx Corp highlights its respiratory device portfolio as investors assess long-term growth prospe - AD HOC NEWS
LUNG News | PULMONX CORP (NASDAQ:LUNG) - ChartMill
Pulmonx Corp (LUNG) Valuation: PE, PB & Fair Value Analysis - TradingKey
Pulmonx Corp. Actuals & Estimates (NASDAQ:LUNG) - TradingView
Pulmonx Corp (LUNG) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Pulmonx Corp (LUNG) Institutional Confidence - TradingKey
Pulmonx Corp (LUNG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Pulmonx Corp (LUNG) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Pulmonx Corp (LUNG) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Pulmonx Corp (LUNG) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Pulmonx Corp (LUNG) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Pulmonx Corp (LUNG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
LUNG SEC FilingsPulmonx Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Pulmonx (LUNG) awards 40,000 restricted stock units to director - Stock Titan
Director Ferrari (LUNG) awarded 40,000 Pulmonx restricted stock units - Stock Titan
Pulmonx Corp (LUNG) director granted 40,000 restricted stock units - Stock Titan
[Form 4] Pulmonx Corp Insider Trading Activity - Stock Titan
Pulmonx (LUNG) director receives 40,000-share RSU stock grant - Stock Titan
Don't Ignore The Insider Selling In Pulmonx - Sahm
Pulmonx (NASDAQ: LUNG) investors back board, auditor and executive pay - Stock Titan
Pulmonx general counsel David Lehman sells $22,474 in stock - Investing.com UK
Pulmonx general counsel David Lehman sells $22,474 in stock By Investing.com - Investing.com India
Pulmonx (LUNG) officer sells 14,497 shares to cover RSU tax withholding - Stock Titan
Pulmonx (LUNG) General Counsel sells 14,594 shares to cover RSU tax obligations - Stock Titan
Pulmonx (LUNG) CCO sells shares to cover RSU tax obligations - Stock Titan
Pulmonx (LUNG) CEO logs 56K-share sale tied to RSU tax withholding - Stock Titan
Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
17 Pulmonx hires receive 84,300 RSUs in Nasdaq inducement plan - Stock Titan
Pulmonx (LUNG) Q1 2026 Earnings Transcript - AOL.com
LUNGPulmonx Corp Stock Price and Quote - Finviz
QTEX Stock Price and Chart — NASDAQ:QTEX - TradingView
Pulmonx (LUNG) Holds Steady Near $1.54 as Key Support and Resistance Levels Define Trading RangeProtective Put - The Legal Advocate
Pulmonx Corp stock (US74586W1018): Q1 2026 results highlight growth path in minimally invasive lung - AD HOC NEWS
Pulmonx Corp stock (US74586W1018): credit line and margin focus keep lung care specialist in the spo - AD HOC NEWS
LUNG Technical Analysis | Trend, Signals & Chart Patterns | PULMONX CORP (NASDAQ:LUNG) - ChartMill
TradingKey - TradingKey
Why Pulmonx Corporation (LUNG) valuation makes sense when you dig deeper (Marginal Loss) 2026-05-11Buffered ETF - Newser
Pulmonx Corporation (LUNG) beats Q1 estimates with EPS improvement despite revenue growth; shares decline as investors focus on losses.AI Trading Community - Newser
Pulmonx Corporation Q1 2026 Financial Report Highlights, Forward-Looking Statements, and Key Risk Factors - Minichart
Pulmonx (NASDAQ: LUNG) secures $40M Perceptive loan and ends Q1 with $61.6M cash - Stock Titan
Pulmonx Corp 1Q 2026: Revenue $20.59M, EPS ($0.33) — 10-Q Summary - TradingView
Pulmonx Corporation (NASDAQ:LUNG) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Pulmonx (NASDAQ:LUNG) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat
Pulmonx Corporation (NASDAQ:LUNG) Q1 2026 Earnings Call Transcript - Insider Monkey
LUNG Maintained by D. Boral Capital -- Price Target Stays at $14 - GuruFocus
Pulmonx Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
Pulmonx's (LUNG) Buy Rating Reiterated at D. Boral Capital - MarketBeat
Pulmonx Corp (LUNG) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic Growth Initiatives - GuruFocus
Is Pulmonx (LUNG) 85.3% Undervalued After Q1 2026 Beats? EPS -$0 - GuruFocus
Pulmonx (LUNG) Projects 2026 Revenue Between $90M and $92M - GuruFocus
Pulmonx Q1 Earnings Call Highlights - MarketBeat
0.35%
0.04%
자본화:
|
볼륨(24시간):